Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PRF TechnologiesPRFX -2.38%22 Operating Cash Flow per Share is $-4.19 as of Jun. 2026. GuruFocus rates PRFX with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 759 Drug Manufacturers companies, PRF Technologies ranks better than 92.75% on this metric.
PRF Technologies's operating cash flow per share for the
six
months ended in Jun. 2026 was $-1.96.
PRF Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was $-4.19.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 70.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 60.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for PRF Technologies's Operating Cash Flow per Share or its related term are showing as below:
PRFX'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -86.1 Med: 51.8 Max: 70.2
Current: 70.2
During the past 8 years, PRF Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 70.20% per year. The lowest was -86.10% per year. And the median was 51.80% per year.
PRFX's 3-Year OCF Growth Rate is ranked better than 92.75% of 759
companies
in the Drug Manufacturers industry
Industry Median: 7.3
vs PRFX: 70.20
PRF Technologies Operating Cash Flow per Share Related Terms
PRF Technologies Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for PRF Technologies's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PRF Technologies Operating Cash Flow per Share Chart
PRFX vs CTTH, UPC, AKAN: Operating Cash Flow per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PRF Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PRF Technologies Price-to-Operating-Cash-Flow vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PRF Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where PRF Technologies's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-4.19
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of $-4.19 mean?
PRF Technologies (PRFX) has a Operating Cash Flow per Share of $-4.19 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on PRF Technologies and its competitors. According to the industry distribution chart, PRF Technologies ranks #55 out of 759 companies in the Drug Manufacturers industry, placing it in the top 7.2%.
Is PRF Technologies' Operating Cash Flow per Share too high?
PRF Technologies' current Operating Cash Flow per Share is $-4.19. Based on the distribution chart, PRF Technologies ranks #55 out of 759 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PRF Technologies has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does PRF Technologies' Operating Cash Flow per Share compare to CTTH and UPC?
According to the Drug Manufacturers industry distribution chart, PRF Technologies ranks #55 out of 759 companies for Operating Cash Flow per Share. This places PRF Technologies in the top 7% of its industry — outperforming the majority of peers. The industry median Operating Cash Flow per Share is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Drug Manufacturers company?
The median Operating Cash Flow per Share among Drug Manufacturers companies is 7.30, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on PRF Technologies and its competitors. For the Drug Manufacturers industry, the median Operating Cash Flow per Share is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PRF Technologies's current Operating Cash Flow per Share is $-4.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PRF Technologies stock overvalued right now?
PRF Technologies (PRFX) has a current Operating Cash Flow per Share of $-4.19. The current Operating Cash Flow per Share is $-4.19. PRF Technologies' overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For PRF Technologies (PRFX), the current Operating Cash Flow per Share is $-4.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
22GF Score
Get the complete analysis for PRFX
Operating Cash Flow per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PRFX has been successfully added to your 
